|
|
Volumn 382, Issue 6589, 1996, Pages 289-
|
|
Rights issue take-up for British biotech 'disappointing'
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
LEXIPAFANT;
MARIMASTAT;
NEW DRUG;
VACCINE;
CLINICAL TRIAL;
DRUG INDUSTRY;
EUROPEAN UNION;
FINANCE;
HUMAN;
MARKET;
NOTE;
ORAL DRUG ADMINISTRATION;
PANCREATITIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
UNITED KINGDOM;
VACCINE PRODUCTION;
|
|
EID: 0029765493
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/382289b0 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|